PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(11 sites)

United States

City of Hope National Medical Center, Duarte, California

Northside Hospital, Atlanta, Georgia

Johns Hopkins Hospital, Baltimore, Maryland

Brigham and Women's Hospital, Boston, Massachusetts

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan